Parabacteroides distasonis
Selected indexed studies
- Gut commensal Parabacteroides distasonis alleviates inflammatory arthritis. (Gut, 2023) [PMID:36604114]
- Parabacteroides distasonis uses dietary inulin to suppress NASH via its metabolite pentadecanoic acid. (Nat Microbiol, 2023) [PMID:37386075]
- Parabacteroides distasonis ameliorates insulin resistance via activation of intestinal GPR109a. (Nat Commun, 2023) [PMID:38007572]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Gut commensal Parabacteroides distasonis alleviates inflammatory arthritis. (2023) pubmed
- Parabacteroides distasonis uses dietary inulin to suppress NASH via its metabolite pentadecanoic acid. (2023) pubmed
- Parabacteroides distasonis ameliorates insulin resistance via activation of intestinal GPR109a. (2023) pubmed
- Parabacteroides distasonis ameliorates hepatic fibrosis potentially via modulating intestinal bile acid metabolism and hepatocyte pyroptosis in male mice. (2023) pubmed
- Parabacteroides distasonis Alleviates Obesity and Metabolic Dysfunctions via Production of Succinate and Secondary Bile Acids. (2019) pubmed
- Therapeutic potential of Parabacteroides distasonis in gastrointestinal and hepatic disease. (2024) pubmed
- Parabacteroides distasonis promotes liver regeneration by increasing β-hydroxybutyric acid (BHB) production and BHB-driven STAT3 signals. (2025) pubmed
- Gut Parabacteroides distasonis-derived Indole-3-Acetic Acid Promotes Phospholipid Remodeling and Enhances Ferroptosis Sensitivity via the AhR-FASN Axis in Bladder Cancer. (2025) pubmed
- Parabacteroides distasonis: intriguing aerotolerant gut anaerobe with emerging antimicrobial resistance and pathogenic and probiotic roles in human health. (2021) pubmed
- Hyodeoxycholic acid alleviates non-alcoholic fatty liver disease through modulating the gut-liver axis. (2023) pubmed